3-nitrotyrosine and Deafness

Mitochondrial diseases (MD) are heterogeneous disorders because of impairment of respiratory chain function leading to oxidative stress. We hypothesized that in MD the vascular endothelium may be affected by increased oxidative/nitrative stress causing a reduction of nitric oxide availability. We therefore, investigated the pathobiology of vasculature in MD patients by assaying the presence of 3-nitrotyrosine in muscle biopsies followed by the proteomic identification of proteins which undergo tyrosine nitration. We then measured the flow-mediated vasodilatation as a proof of altered nitric oxide generation/bioactivity. Here, we show that 3-nitrotyrosine staining is specifically located in the small vessels of muscle tissue and that the reaction is stronger and more evident in a significant percentage of vessels from MD patients as compared with controls. Eleven specific proteins which are nitrated under pathological conditions were identified; most of them are involved in energy metabolism and are located mainly in mitochondria. In MD patients the flow-mediated vasodilatation was reduced whereas baseline arterial diameters, blood flow velocity and endothelium-independent vasodilatation were similar to controls. The present results provide evidence that in MD the vessel wall is a target of increased oxidative/nitrative stress.

Topics: Adolescent; Adult; Aged; Base Sequence; Brachial Artery; Case-Control Studies; Deafness; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Femoral Artery; Humans; Kearns-Sayre Syndrome; Male; MELAS Syndrome; MERRF Syndrome; Middle Aged; Mitochondrial Diseases; Muscle, Skeletal; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Point Mutation; Sequence Deletion; Tyrosine; Vasodilation